Alamar CFO reports 570,719-share stock option

Alamar Biosciences, Inc. Chief Financial Officer Justin J. McAnear reported his initial holdings of a stock option to buy Class B common stock.

Rhea-AI Filing Summary

Alamar Biosciences, Inc. Chief Financial Officer Justin J. McAnear reported his initial holdings of a stock option to buy Class B common stock. The option covers 570,719 underlying shares at an exercise price of $4.62 per share and expires on October 14, 2035.

According to the vesting terms, 25% of the shares subject to the option vest on October 13, 2026, and 1/48th of the shares vest monthly thereafter, as long as McAnear continues providing service through each vesting date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider McAnear Justin J.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 570,719 contracts (Direct)

Footnotes (1)

1. F1. Twenty-five percent of the shares subject to the option vest on 10/13/2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date.

Key Figures

Underlying option shares: 570,719 shares Exercise price: $4.62 per share Option expiration: October 14, 2035 +2 more

5 metrics

Underlying option shares 570,719 shares Class B common stock underlying CFO stock option

Exercise price $4.62 per share Stock option exercise price for Class B common stock

Option expiration October 14, 2035 Expiration date of CFO stock option

Initial vesting date October 13, 2026 25% of option shares vest on this date

Ongoing vesting rate 1/48th monthly Portion of option shares vesting each month after initial cliff

Key Terms

Stock Option (Right to Buy), Class B Common Stock, vesting, continuous service

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

Class B Common Stock financial

"underlying_security_title: Class B Common Stock"

A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.

vesting financial

"Twenty-five percent of the shares subject to the option vest on 10/13/2026"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

continuous service financial

"subject to the reporting person's continuous service through each such vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Alamar Biosciences (ALMR) CFO Justin McAnear report on his Form 3?

Alamar Biosciences CFO Justin J. McAnear reported his initial beneficial ownership of a stock option. The option gives him the right to buy Class B common stock under specific vesting terms, documenting his starting equity position as an officer.

How many shares are covered by Justin McAnear’s stock option at Alamar Biosciences (ALMR)?

The stock option held by Justin McAnear covers 570,719 underlying shares of Class B common stock. This figure reflects the number of shares tied to the option as reported, not current common stock ownership from exercised shares.

What is the exercise price and expiration date of the ALMR CFO’s stock option?

Justin McAnear’s stock option has an exercise price of $4.62 per share and an expiration date of October 14, 2035. These terms define the cost to purchase shares and the latest date the option can be exercised.

How does the vesting schedule work for Justin McAnear’s Alamar Biosciences stock option?

Twenty-five percent of the option shares vest on October 13, 2026, with 1/48th of the shares vesting monthly thereafter. Vesting requires McAnear’s continuous service through each vesting date, aligning equity benefits with ongoing employment.

Does the Alamar Biosciences (ALMR) Form 3 show any stock purchases or sales by the CFO?

The Form 3 describes a stock option holding rather than stock purchases or sales. It reports McAnear’s right to buy Class B common shares under defined terms, without indicating open-market buy or sell transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/16/2026 - 09:16 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

McAnear Justin J.

(Last) (First) (Middle)

C/O ALAMAR BIOSCIENCES, INC.

47071 BAYSIDE PARKWAY

(Street)

FREMONT CALIFORNIA 94538

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/16/2026

3. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	10/14/2035	Class B Common Stock	570,719	$4.62	D

Explanation of Responses:

1. Twenty-five percent of the shares subject to the option vest on 10/13/2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date.

	/s/ Justin J. McAnear	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)